Non invaziv prenatal tanı testlerinin geleceği ve etik sorunlar

Zhang H, Denona B. Noninvasive prenatal testing test versus chorionic villus sampling, where are we now? Matern Med. 2024;6(2):128-130.

Ravitsky V, Roy M-C, Haidar H, Henneman L, Marshall J, Newson AJ, et al. The emergence and global spread of noninvasive prenatal testing. annu rev genomics hum genet. 2021;22:309–338.

Jayashankar SS, Nasaruddin ML, Hassan MF, Dasrilsyah RA, Shafiee MN, Ismail NA, et al. Non-invasive prenatal testing (NIPT): reliability, challenges, and future directions. Diagnostics. 2023;13(15):2570.

Peahl AF, Turrentine M, Srinivas S, King T, Zahn CM. Routine prenatal care. Obstet Gynecol Clin North Am. 2023;50(3):439–455.

LeFevre NM, Sundermeyer RL. Fetal aneuploidy: screening and diagnostic testing. Am Fam Physician. 2020;101(8):481–488.

Hanson B, Scotchman E, Chitty LS, Chandler NJ. Non-invasive prenatal diagnosis (NIPD): how analysis of cell-free DNA in maternal plasma has changed prenatal diagnosis for monogenic disorders. Clin Sci (Lond). 2022;136(22):1615–1629.

Motlagh H, Dorgalaleh A, Tabibian S, Naderi M, Zaker F. Noninvasive prenatal diagnosis of congenital factor XIII deficiency in Iran. Blood Coagul fibrinolysis an Int J Haemost Thromb. 2022;33(3):167–170.

Everett TR, Chitty LS. Cell-free fetal DNA: the new tool in fetal medicine. Vol. 45, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. England; 2015.

Lee DE, Kim H, Park J, Yun T, Park DY, Kim M, et al. Clinical Validation of non-ınvasive prenatal testing for fetal common aneuploidies in 1,055 korean pregnant women: a single center experience. J Korean Med Sci. 2019;34(24):e172.

Abedalthagafi M, Bawazeer S, Fawaz RI, Heritage AM, Alajaji NM, Faqeih E. Non-invasive prenatal testing: a revolutionary journey in prenatal testing. Front Med. 2023;10:1265090.

Liehr T, Lauten A, Schneider U, Schleussner E, Weise A. Noninvasive prenatal testing - when ıs ıt advantageous to apply. Biomed hub. 2017;2(1):1–11.

Wulff CB, Gerds TA, Rode L, Ekelund CK, Petersen OB, Tabor A. Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2016;47(1):38–44.

Kong X, Zhang L, Yang R, Zhang H, Ren M, Wang X, et al. Reasons for failure of noninvasive prenatal test for cell-free fetal DNA in maternal peripheral blood. Mol Genet genomic Med. 2024;12(1):e2351.

Zhang M, Tang J, Li J, Wang C, Wei R, Fang Y, et al. Value of noninvasive prenatal testing in the detection of rare fetal autosomal abnormalities. Eur J Obstet Gynecol Reprod Biol. 2023;284:5–11.

Marks IR, Mills C, Devolder K. Unconditional access to non-invasive prenatal testing (NIPT) for adult-onset conditions: a defence. J Med Ethics. 2024;50(2):102–7.

Chiu RWK, Akolekar R, Zheng YWL, Leung TY, Sun H, Chan KCA, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ. 2011;342:c7401.

Gadsbøll K, Petersen OB, Gatinois V, Strange H, Jacobsson B, Wapner R, et al. Current use of noninvasive prenatal testing in Europe, Australia and the USA: a graphical presentation. Acta Obstet Gynecol Scand. 2020;99(6):722–30.

Agarwal A, Sayres LC, Cho MK, Cook-Deegan R, Chandrasekharan S. Commercial landscape of noninvasive prenatal testing in the United States. Prenat Diagn. 2013;33(6):521–31.

Ukonaho T-T. Global scenarios in maternal and fetal health diagnostics business in year 2030: analysis, conclusions and suggestions. 2024;

Nshimyumukiza L, Beaumont JA, Rousseau F, Reinharz D. Introducing cell-free DNA noninvasive testing in a Down syndrome public health screening program: a budget impact analysis. Cost Eff Resour Alloc. 2020;18:1–9.

Johnston M, Hui L, Bowman-Smart H, Taylor-Sands M, Pertile MD, Mills C. Disparities in integrating non-invasive prenatal testing into antenatal healthcare in Australia: a survey of healthcare professionals. BMC Pregnancy Childbirth. 2024;24(1):355.

McMahon G, Kennedy S, Miremberg H, O’Donoghue K. Non-invasive prenatal testing: Assessing the availability and accessibility of information available to the pregnant population within the Republic of Ireland. Eur J Obstet Gynecol Reprod Biol. 2024;302:149–154.

van Prooyen Schuurman L, van der Meij K, van Ravesteyn N, Crombag N, Gitsels-van der Wal J, Kooij C, et al. Factors involved in the decision to decline prenatal screening with noninvasive prenatal testing (NIPT). Prenat Diagn. 2023;43(4):467–76.

Mei L, Tang Q, Sun B, Xu L. Noninvasive prenatal testing in China: Future detection of rare genetic diseases? Intractable rare Dis Res. 2014;3(3):87–90.

Wu L, Wu Y, Zou S, Sun C, Chen J, Li X, et al. Eliciting women’s preference for prenatal testing in China: a discrete choice experiment. BMC Pregnancy Childbirth. 2020;20(1):604.

Sasaki A, Sawai H, Masuzaki H, Hirahara F, Sago H. Low prevalence of genetic prenatal diagnosis in Japan. Prenat Diagn. 2011;31(10):1007–1009.

Kimura M. Experiences related to prenatal testing among Japanese mothers of children with disabilities. Women’s Reprod Heal. 2018;5(3):183–203.

Pistorius L, Cluver C, Bhorat I, Hall C, Smit L, Scott C, et al. Screening for chromosomal and structural fetal anomalies: guidelines for South African private practice. African J Obstet Gynaecol. 2023;1(2):19–24.

UK National Screening Committee. The UK NSC Recommendation on Down’s Syndrome Screening in Pregnancy. 2016.

UK National Screening Committee. UK National Screening Committee Annual Report 2019 to 2020. 2023.

Perrot A, Horn R. The ethical landscape (s) of non-invasive prenatal testing in England, France and Germany: findings from a comparative literature review. Eur J Hum Genet. 2022;30(6):676–681.

Kolleck A, Sauter A. Aktueller Stand und Entwicklungen der Pränataldiagnostik. Endbericht zum Monitoring. 2019.

Perrot A, Horn R. Health professionals and scientists’ views on genome-wide NIPT in the French public health system: Critical analysis of the ethical issues raised by prenatal genomics. PLoS One. 2022;17(11):e0277010.

Vassy C, Noiville C, Brunet L. The regulation of non-ınvasive prenatal testing (NIPT) in France: Continuity and changes in the development of prenatal testing. OBM Genet. 2022;6(1):1–15.

Palomaki GE, Knight GJ, Ashwood ER, Best RG, Haddow JE. Screening for down syndrome in the United States: results of surveys in 2011 and 2012. Arch Pathol Lab Med. 2013;137(7):921–926.

Haymon L, Simi E, Moyer K, Aufox S, Ouyang DW. Clinical implementation of noninvasive prenatal testing among maternal fetal medicine specialists. Prenat Diagn. 2014;34(5):416–423.

Gregg AR, Gross SJ, Best RG, Monaghan KG, Bajaj K, Skotko BG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med. 2013;15(5):395–398.

Schmitz D, Netzer C, Henn W. An offer you can’t refuse? Ethical implications of non-invasive prenatal diagnosis. Nat Rev Genet. 2009;10(8):515.

Xue Y, Zhao G, Qiao L, Lu J, Yu B, Wang T. Sequencing shorter cfDNA Fragments decreases the false negative rate of non-invasive prenatal testing. Front Genet. 2020;11:280.

Dai R, Yu Y, Zhang H, Li L, Jiang Y, Liu R, et al. Analysis of 17,428 pregnant women undergoing non-invasive prenatal testing for fetal chromosome in Northeast China. Medicine (Baltimore). 2021;100(6):e24740.

Hartwig TS, Ambye L, Sørensen S, Jørgensen FS. Discordant non-invasive prenatal testing (NIPT) - a systematic review. Prenat Diagn. 2017;37(6):527–539.

Minarik G, Repiska G, Hyblova M, Nagyova E, Soltys K, Budis J, et al. Utilization of benchtop next generation sequencing platforms ıon torrent pgm and miseq in noninvasive prenatal testing for chromosome 21 trisomy and testing of ımpact of ın silico and physical size selection on ıts analytical performance. PLoS One. 2015;10(12):e0144811.

Grati FR, Ferreira J, Benn P, Izzi C, Verdi F, Vercellotti E, et al. Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA. Genet Med Off J Am Coll Med Genet. 2020;22(2):309–316.

Lau TK, Cheung SW, Lo PSS, Pursley AN, Chan MK, Jiang F, et al. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2014;43(3):254–264.

Porreco RP, Garite TJ, Maurel K, Marusiak B, Ehrich M, van den Boom D, et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol. 2014;211(4):365.e1-e12.

Wang S, Huang S, Ma L, Liang L, Zhang J, Zhang J, et al. Maternal X chromosome copy number variations are associated with discordant fetal sex chromosome aneuploidies detected by noninvasive prenatal testing. Clin Chim Acta. 2015;444:113–116.

Osborne CM, Hardisty E, Devers P, Kaiser-Rogers K, Hayden MA, Goodnight W, et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn. 2013;33(6):609–611.

Brady P, Brison N, Van Den Bogaert K, de Ravel T, Peeters H, Van Esch H, et al. Clinical implementation of NIPT - technical and biological challenges. Clin Genet. 2016;89(5):523–530.

Mayes S, Hashmi S, Turrentine MA, Darilek S, Friel LA, Czerwinski J. Obstetrician and gynecologist utilization of the noninvasive prenatal testing expanded option. Vol. 6, AJP reports. United States; 2016.

Kater-Kuipers A, Bunnik EM, de Beaufort ID, Galjaard RJH. Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals. BMC Pregnancy Childbirth. 2018;18(1):409.

Ahmed S, Jafri H, Rashid Y, Mason G, Ehsan Y, Ahmed M. Attitudes towards non-invasive prenatal diagnosis among obstetricians in Pakistan, a developing, Islamic country. Prenat Diagn. 2017;37(3):289–95.

Haidar H, Vanstone M, Laberge A-M, Bibeau G, Ghulmiyyah L, Ravitsky V. Cross-cultural perspectives on decision making regarding noninvasive prenatal testing: A comparative study of Lebanon and Quebec. AJOB Empir Bioeth. 2018;9(2):99–111.

Foth H. Avoiding “selection”?-References to history in current German policy debates about non-invasive prenatal testing. Bioethics. 2021;35(6):518–527.

Magelssen M. Prenatal diagnosis and the christian health professional. Christ Bioeth Non-Ecumenical Stud Med Moral. 2016;22(3):325–339.

Benn P, Cuckle H. Theoretical performance of non-invasive prenatal testing for chromosome imbalances using counting of cell-free DNA fragments in maternal plasma. Prenat Diagn. 2014;34(8):778–783.

Bianchi DW, Parker RL, Wentworth J, Madankumar R, Saffer C, Das AF, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med. 2014;370(9):799–808.

Smith M, Lewis KM, Holmes A, Visootsak J. A case of false negative NIPT for down syndrome-lessons learned. Case Rep Genet. 2014;2014(1):823504.

Verweij EJ, de Boer MA, Oepkes D. Non-invasive prenatal testing for trisomy 13: more harm than good? Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2014;44(1):112–114.

Srebniak MI, Diderich KEM, Noomen P, Dijkman A, De Vries FAT, Van Opstal D. Abnormal non-invasive prenatal test results concordant with karyotype of cytotrophoblast but not reflecting abnormal fetal karyotype. Ultrasound Obstet Gynecol. 2014;44(1):109–111.

Platt LD, Janicki MB, Prosen T, Goldberg JD, Adashek J, Figueroa R, et al. Impact of noninvasive prenatal testing in regionally dispersed medical centers in the United States. Am J Obstet Gynecol. 2014;211(4):368-371.

Manegold-Brauer G, Bellin AK, Hahn S, De Geyter C, Buechel J, Hoesli I, et al. A new era in prenatal care: non-invasive prenatal testing in Switzerland. Swiss Med Wkly. 2014;144(0506):w13915.

Pettit KE, Hull AD, Korty L, Jones MC, Pretorius DH. Noninvasive prenatal testing: a replacement for chorionic villus sampling and amniocentesis for advanced maternal age? Obstet Gynecol. 2014;123:165S-166S.

Rad S, Turner AL, Beauchamp S, Aghajanian P, Williams III J, Esakoff TF. Noninvasive prenatal testing compared with invasive diagnostic testing in the setting of an abnormal state aneuploidy screen. Obstet Gynecol. 2014;123:100S.

O’Leary P, Maxwell S, Murch A, Hendrie D. Prenatal screening for D own syndrome in A ustralia: Costs and benefits of current and novel screening strategies. Aust New Zeal J Obstet Gynaecol. 2013;53(5):425–433.

Morris S, Karlsen S, Chung N, Hill M, Chitty LS. Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down’s syndrome using cell free fetal DNA in the UK National Health Service. PLoS One. 2014;9(4):e93559.

Ohno M, Caughey A. The role of noninvasive prenatal testing as a diagnostic versus a screening tool–a cost-effectiveness analysis. Prenat Diagn. 2013;33(7):630–635.

Song K, Musci TJ, Caughey AB. Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population. J Matern neonatal Med. 2013;26(12):1180–1185.

Johnston M, Warton C, Pertile MD, Taylor-Sands M, Delatycki MB, Hui L, et al. Ethical issues associated with prenatal screening using non-invasive prenatal testing for sex chromosome aneuploidy. Prenat Diagn. 2023;43(2):226–234.

Kater-Kuipers A, De Beaufort ID, Galjaard RH, Bunnik EM. Rethinking counselling in prenatal screening: an ethical analysis of informed consent in the context of non-invasive prenatal testing (NIPT). Bioethics. 2020;34(7):671–678.

Qi Q-G, Tuo Y, Liu L-X, Yu C-X, Wu A-N. Amniocentesis and next generation sequencing (NGS)-based noninvasive prenatal DNA testing (NIPT) for prenatal diagnosis of fetal chromosomal disorders. Int J Gen Med. 2021;14:1811–1817.

Adra A, Khalife D, Usta IM, Hobeika E, Mirza F, Ghulmiyyah L, et al. Practice patterns of obstetric care in twin gestations: the value of MFM consultation. J Matern neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2022;35(18):3453–3459.

Long S, O’Leary P, Dickinson JE. Women’s responses to prenatal genetic diagnosis and attitudes to termination of pregnancy after non-invasive prenatal testing: An online survey of Western Australian women. Aust N Z J Obstet Gynaecol. 2023;63(2):219–227.

Glad R. Prenatal testing - universal access? Tidsskr Nor Laegeforen. 2022;142(8). Available from: https://tidsskriftet.no/en/2022/05/editorial/prenatal-testing-universal-access

Bunnik EM, Kater-Kuipers A, Galjaard R-JH, de Beaufort ID. Should pregnant women be charged for non-invasive prenatal screening? Implications for reproductive autonomy and equal access. J Med Ethics. 2020;46(3):194–198.

Kater-Kuipers A, Bakkeren IM, Riedijk SR, Go ATJI, Polak MG, Galjaard R-JH, et al. Non-invasive prenatal testing (NIPT): societal pressure or freedom of choice? A vignette study of Dutch citizens’ attitudes. Eur J Hum Genet. 2021;29(1):2–10.

Dufner A. Non-invasive prenatal testing (NIPT): does the practice discriminate against persons with disabilities? J Perinat Med. 2021;49(8):945–948.

Rehmann-Sutter C. Should prenatal screening be seen as “selective reproduction”? Four reasons to reframe the ethical debate. J Perinat Med. 2021;49(8):953–958.

Montgomery S, Thayer ZM. The influence of experiential knowledge and societal perceptions on decision-making regarding non-invasive prenatal testing (NIPT). BMC Pregnancy Childbirth. 2020;20(1):630.

Bakkeren IM, Kater-Kuipers A, Bunnik EM, Go ATJI, Tibben A, de Beaufort ID, et al. Implementing non-invasive prenatal testing (NIPT) in the Netherlands: An interview study exploring opinions about and experiences with societal pressure, reimbursement, and an expanding scope. J Genet Couns. 2020;29(1):112–121.

Rueda J, Vallès-Poch M. Genomic uncertainty as a burden for reproductive choice? the problem of probabilistic causation in non-ınvasive prenatal testing. Am J Bioeth. 2023;23(3):26–28.

Denneny M. Decoding Promises and Perceptions: A reflexive thematic analysis of the online presentation of noninvasive prenatal testing (NIPT) in Top U.S. Brands. J Consum Health Internet. 2024;28(2):135–156.